Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-8448b6f56d-mp689 Total loading time: 0 Render date: 2024-04-16T22:55:10.733Z Has data issue: false hasContentIssue false

Chapter 14 - Management of treatment-related behavioral disturbances in Parkinson's disease

from Section II - Management of Nonmotor Symptoms of Parkinson's Disease

Published online by Cambridge University Press:  05 March 2016

By
Mayur Pandya ,
Dimitrios A. Nacopoulos  and
Naveed Khokhar
Edited by
Néstor Gálvez-Jiménez ,
Hubert H. Fernandez ,
Alberto J. Espay  and
Susan H. Fox
Néstor Gálvez-Jiménez
Affiliation:
Cleveland Clinic, Florida
Hubert H. Fernandez
Affiliation:
Cleveland Clinic, Ohio
Alberto J. Espay
Affiliation:
University of Cincinnati
Susan H. Fox
Affiliation:
Toronto Western Hospital
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Parkinson's Disease
Current and Future Therapeutics and Clinical Trials
 , pp. 139 - 150
Publisher: Cambridge University Press
Print publication year: 2016

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Tang, J, Strafella, AP. The frontostriatal circuitry and behavioral complications in PD. Parkinsonism Relat Disord 2012; 18 (Suppl. 1): S104–6.CrossRefGoogle ScholarPubMed
Aarons, S, Peisah, C, Wijeratne, C. Neuropsychiatric effects of Parkinson's disease treatment. Australas J Ageing 2012; 31: 198–202.Google Scholar
Huot, P, Fox, SH. The serotonergic system in motor and non-motor manifestations of Parkinson's disease. Exp Brain Res 2013; 230: 463–76.Google Scholar
Rabinak, CA, Nirenberg, MJ. Dopamine agonist withdrawal syndrome in Parkinson disease. Arch Neurol 2010; 67: 58–63.Google Scholar
Connolly, BS, Fox, SH. Drug treatments for the neuropsychiatric complications of Parkinson's disease. Expert Rev Neurother 2012; 12: 1439–49.Google Scholar
Friedman, JH. Parkinson disease psychosis: update. Behav Neurol 2013; 27: 469–77.Google Scholar
Ravina, B, Marder, K, Fernandez, HH, et al. Diagnostic criteria for psychosis in Parkinson's disease: report of an NINDS, NIMH work group. Mov Disord 2007; Jun 15; 22: 1061–8.Google Scholar
Mack, J, Rabins, P, Anderson, K, et al. Prevalence of psychotic symptoms in a community-based Parkinson disease sample. Am J Geriatr Psychiatry 2012; 20: 123–32.CrossRefGoogle Scholar
Goldman, JG. New thoughts on thought disorders in Parkinson's disease: review of current research strategies and challenges. Parkinsons Dis 2011; 2011: 675630.Google Scholar
Emre, M, Aarsland, D, Albanese, A, et al. Rivastigmine for dementia associated with Parkinson's disease. N Engl J Med 2004; 351: 2509–18.Google Scholar
Meltzer, HY, Massey, BW. The role of serotonin receptors in the action of atypical antipsychotic drugs. Curr Opin Pharmacol 2011; 11: 59–67.Google Scholar
Ballanger, B, Strafella, AP, van Eimeren, T, et al. Serotonin 2A receptors and visual hallucinations in Parkinson disease. Arch Neurol 2010; 67: 416–21.CrossRefGoogle ScholarPubMed
Hindle, JV. The practical management of cognitive impairment and psychosis in the older Parkinson's disease patient. J Neural Transm 2013; 120: 649–53.CrossRefGoogle ScholarPubMed
Seppi, K, Weintraub, D, Coelho, M, et al. The Movement Disorder Society evidence-based medicine review update: treatments for the non-motor symptoms of Parkinson's disease. Mov Disord 2011; 26: 42–78.Google Scholar
Weintraub, D, Chen, P, Ignacio, RV, Mamikonyan, E, Kales, HC. Patterns and trends in antipsychotic prescribing for Parkinson disease psychosis. Arch Neurol 2011; 68: 899–904.Google Scholar
Cummings, J, Isaacson, S, Mills, R, et al. Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial. Lancet 2014; 383: 533–40.CrossRefGoogle ScholarPubMed
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn, Text Revision. Washington, DC: American Psychiatric Association Press, 1994.Google Scholar
Evans, AH, Strafella, AP, Weintraub, D, Stacy, M. Impulsive and compulsive behaviors in Parkinson's disease. Mov Disord 2009; 24: 1561–70.CrossRefGoogle ScholarPubMed
Maier, F, Merkl, J, Ellereit, AL, et al. Hypomania and mania related to dopamine replacement therapy in Parkinson's disease. Parkinsonism Relat Disord 2014; 20: 421–7.Google Scholar
Voon, V, Fox, SH. Medication-related impulse control and repetitive behaviors in Parkinson disease. Arch Neurol 2007; 64: 1089–96.CrossRefGoogle ScholarPubMed
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th edn. Washington, DC: American Psychiatric Publishing, 2013.Google Scholar
Evans, AH, Katzenschlager, R, Paviour, D, et al. Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome. Mov Disord 2004; 19: 397–405.Google Scholar
Okai, D, Samuel, M, Askey-Jones, S, David, AS, Brown, RG. Impulse control disorders and dopamine dysregulation in Parkinson's disease: a broader conceptual framework. Eur J Neurol 2011; 18: 1379–83.Google Scholar
Driver-Dunckley, E, Samanta, J, Stacy, M. Pathological gambling associated with dopamine agonist therapy in Parkinson's disease. Neurology 2003; 61: 422–3.CrossRefGoogle ScholarPubMed
Weintraub, D, Koester, J, Potenza, MN, et al. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 2010; 67: 589–95.Google Scholar
Garcia-Ruiz, PJ, Martinez Castrillo, JC, Alonso-Canovas, A, et al. Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study. J Neurol Neurosurg Psychiatry 2014; 85: 840–4.Google Scholar
Gerlach, M, Double, K, Arzberger, T, et al. Dopamine receptor agonists in current clinical use: comparative dopamine receptor binding profiles defined in the human striatum. J Neural Transm 2003; 110: 1119–27.CrossRefGoogle ScholarPubMed
Yin, HH, Knowlton, BJ. The role of the basal ganglia in habit formation. Nat Rev Neurosci 2006; 7: 464–76.Google Scholar
Rao, H, Mamikonyan, E, Detre, JA, et al. Decreased ventral striatal activity with impulse control disorders in Parkinson's disease. Mov Disord 2010; 25: 1660–9.Google Scholar
Voon, V, Rizos, A, Chakravartty, R, et al. Impulse control disorders in Parkinson's disease: decreased striatal dopamine transporter levels. J Neurol Neurosurg Psychiatry 2014; 85: 148–52.Google Scholar
Weintraub, D, Mamikonyan, E, Papay, K, et al. Questionnaire for impulsive-compulsive disorders in Parkinson's disease – rating scale. Mov Disord 2012; 27: 242–7.Google Scholar
Sohtaoğlu, M, Demiray, DY, Kenangil, G, Ozekmekçi, S, Erginöz, E. Long term follow-up of Parkinson's disease patients with impulse control disorders. Parkinsonism Relat Disord 2010; 16: 334–7.Google Scholar
Catalán, MJ, de Pablo-Fernández, E, Villanueva, C, et al. Levodopa infusion improves impulsivity and dopamine dysregulation syndrome in Parkinson's disease. Mov Disord 2013; 28: 2007–10.Google Scholar
Katzenschlager, R. Dopamine dysregulation syndrome in Parkinson's disease. J Neurol Sci 2011; 310: 271–5.CrossRefGoogle ScholarPubMed
Kringelbach, ML, Berridge, KC. Towards a functional neuroanatomy of pleasure and happiness. Trends Cogn Sci. 2009; 13: 479–87.Google Scholar
Giovannoni, G, O'sullivan, JD, Turner, K, Manson, AJ, Lees, AJ. Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies. J Neurol Neurosurg Psychiatry 2000; 68: 423–8.CrossRefGoogle ScholarPubMed
Cilia, R, Siri, C, Canesi, M, et al. Dopamine dysregulation syndrome in Parkinson's disease: from clinical and neuropsychological characterisation to management and long-term outcome. J Neurol Neurosurg Psychiatry 2014; 85: 311–8.CrossRefGoogle ScholarPubMed
Evans, AH, Pavese, N, Lawrence, AD, et al. Compulsive drug use linked to sensitized ventral striatal dopamine transmission. Ann Neurol 2006; 59: 852–8.CrossRefGoogle ScholarPubMed
Linazasoro, G. Dopamine dysregulation syndrome and levodopa-induced dyskinesias in Parkinson disease: common consequences of anomalous forms of neural plasticity. Clin Neuropharmacol 2009; 32: 22–7.Google Scholar
Okun, MS, Weintraub, D. Should impulse control disorders and dopamine dysregulation syndrome be indications for deep brain stimulation and intestinal levodopa? Mov Disord 2013; 28: 1915–9.Google Scholar
Pondal, M, Marras, C, Miyasaki, J, et al. Clinical features of dopamine agonist withdrawal syndrome in a movement disorders clinic. J Neurol Neurosurg Psychiatry 2013; 84: 130–5.CrossRefGoogle Scholar
Limotai, N, Oyama, G, Go, C, et al. Addiction-like manifestations and Parkinson's disease: a large single center 9-year experience. Int J Neurosci 2012; 122: 145–53.Google Scholar
Thobois, S, Ardouin, C, Lhommée, E, et al. Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation. Brain 2010; 133: 1111–27.Google Scholar
Nirenberg, MJ. Dopamine agonist withdrawal syndrome: implications for patient care. Drugs Aging 2013; 30: 587–92.Google Scholar
Cunnington, AL, White, L, Hood, K. Identification of possible risk factors for the development of dopamine agonist withdrawal syndrome in Parkinson's disease. Parkinsonism Relat Disord 2012; 18: 1051–2.CrossRefGoogle ScholarPubMed
Bronstein, JM, Tagliati, M, Alterman, RL, et al. Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues. Arch Neurol 2011; 68: 165.CrossRefGoogle ScholarPubMed
Voon, V, Kubu, C, Krack, P, Houeto, JL, Tröster, AI. Deep brain stimulation: neuropsychological and neuropsychiatric issues. Mov Disord 2006; 21 (Suppl. 14): S305–27.Google Scholar
Greenberg, BD, Gabriels, LA, Malone, DA Jr, et al. Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder: worldwide experience. Mol Psychiatry. 2010; 15: 64–79.Google Scholar
Temel, Y, Kessels, A, Tan, S, et al. Behavioural changes after bilateral subthalamic stimulation in advanced Parkinson disease: a systematic review. Parkinsonism Relat Disord 2006; 12: 265–72.Google Scholar
Funkiewiez, A, Ardouin, C, Krack, P, et al. Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease. Mov Disord 2003; 18: 524–30.Google Scholar
Follett, KA, Weaver, FM, Stern, M, et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. N Engl J Med 2010; 362: 2077–91.Google Scholar
Witt, K, Daniels, C, Volkmann, J. Factors associated with neuropsychiatric side effects after STN-DBS in Parkinson's disease. Parkinsonism Relat Disord 2012; 18(Suppl. 1): S168–70.CrossRefGoogle ScholarPubMed
Temel, Y. Limbic effects of high-frequency stimulation of the subthalamic nucleus. Vitam Horm 2010; 82: 47–63.CrossRefGoogle ScholarPubMed
Okun, MS, Fernandez, HH, Wu, SS, et al. Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPARE trial. Ann Neurol 2009; 65: 586–95.Google Scholar
Odekerken, VJ, van Laar, T, Staal, MJ, et al. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial. Lancet Neurol 2013; 12: 37–44.CrossRefGoogle ScholarPubMed
Klaming, L, Haselager, P. Did my brain implant make me do it? Questions raised by DBS regarding psychological continuity, responsibility for action and mental competence. Neuroethics 2013; 6: 527–39.Google Scholar
Rodriguez, RL, Fernandez, HH, Haq, I, Okun, MS. Pearls in patient selection for deep brain stimulation. Neurologist. 2007; 13: 253–60.CrossRefGoogle ScholarPubMed
Broen, M, Duits, A, Visser-Vandewalle, V, Temel, Y, Winogrodzka, A. Impulse control and related disorders in Parkinson's disease patients treated with bilateral subthalamic nucleus stimulation: a review. Parkinsonism Relat Disord 2011; 17: 413–7.Google Scholar
Kirsch-Darrow, L, Zahodne, LB, Marsiske, M, et al. The trajectory of apathy after deep brain stimulation: from pre-surgery to 6 months post-surgery in Parkinson's disease. Parkinsonism Relat Disord 2011; 17: 182–8.Google Scholar
Campbell, MC, Black, KJ, Weaver, PM, et al. Mood response to deep brain stimulation of the subthalamic nucleus in Parkinson's disease. J Neuropsychiatry Clin Neurosci. 2012; 24: 28–36.Google Scholar
Voon, V, Krack, P, Lang, AE, et al. A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease. Brain 2008; 131: 2720–8.Google Scholar
Weintraub, D, Duda, JE, Carlson, K, et al. Suicide ideation and behaviours after STN and GPi DBS surgery for Parkinson's disease: results from a randomised, controlled trial. J Neurol Neurosurg Psychiatry 2013; 84: 1113–18.Google Scholar
Struhal, W, Guger, M, Hödl, S, et al. Attempted suicide under high dose dopaminergic therapy including apomorphine. Wien Klin Wochenschr 2012; 124: 461–3.Google Scholar
Pandya, M, Machado, A, Malone, D. Depression in humans: the ventral capsule/ventral striatum. In: Denys, D, Feenstra, E, Schuurman, R, eds. Deep Brain Stimulation: A New Frontier in Psychiatry; 2012; 95–102.Google Scholar
Saleh, C. How to treat DBS-induced mania? J Neurol Sci 2011; 301: 116.CrossRefGoogle ScholarPubMed
Moum, SJ, Price, CC, Limotai, N, et al. Effects of STN and GPi deep brain stimulation on impulse control disorders and dopamine dysregulation syndrome. PLoS One 2012; 7: e29768.Google Scholar
Eusebio, A, Witjas, T, Cohen, J, et al. Subthalamic nucleus stimulation and compulsive use of dopaminergic medication in Parkinson's disease. J Neurol Neurosurg Psychiatry 2013; 84: 868–74.CrossRefGoogle ScholarPubMed
Shotbolt, P, Moriarty, J, Costello, A, et al. Relationships between deep brain stimulation and impulse control disorders in Parkinson's disease, with a literature review. Parkinsonism Relat Disord 2012; 18: 10–16.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×